65,437 trials
Uterine Cervical Neoplasms · Sexually Transmitted Diseases
Primary: Concordance Between Vaginal Self-swab Results and Provider-collected Cervical Swab Results for HPV DNA Among Sexually Active FTM Adults — 15; 2; 6; 108 Participants…
Prostate Cancer
Primary: Number of Patients Experiencing Decline in Prostate-specific Antigen — 2 Participants
Obesity · Diabetes · Hypertension
Primary: Change in Abdominal Fat Mass — -192.6; -21.9; -275 Cubic cm
Symptomatic Menopause · Cognitive Impairments
Primary: Brown Attention Deficit Disorder Scale (BADDS) — 35.7; 21.2; 29.8 units on a scale
Autosomal Dominant Polycystic Kidney Disease
Primary: Mean Change From Baseline in Measured Glomerular Filtration Rate (mGFR) After 3 Weeks of Tolvaptan Treatment and at 3 Weeks Post Treatment. — -8.0; -6.2; -0.7; 0.1…
Deep Sedation · Anesthesia, General
Primary: The Effect of Nitrous Oxide on Bispectral Index (BIS) and State Entropy Index (SE) — 36; 40; 32; 39 units on a scale
HIV
Primary: Change in Working Memory — 51.33; 43.15 mean T score on working memory tests — p=.013
Acne Vulgaris
Primary: Mean Percent Change in the Number of Inflamed Lesions (Papules/Pustules) — 72.3; 71.1; 39.1 percentage change from baseline
Myocardial Ischemia
Primary: Area Under the Curve of etSEV Over the First Hour — 1.77; 1.46; 1.73 percent*hour
Varicella
Primary: Antibody Titers Against Varicella Zoster Virus (VZV) — 172.6; 154.3 Titers
Syncope, Vasovagal, Neurally-Mediated
Primary: The Primary Outcome Measure Will be the Recurrence of Syncope in Follow up Period. — 42; 54 Participants
Obstructive Sleep Apnea
Primary: Sensitivity and Specificity — 79.0; 88.2 percentage
Traumatic Brain Injury · Posttraumatic Epilepsy
Primary: Extended Glasgow Outcome Scale (GOS-E) Score — 4.2; 4.3 GOS-E Score
Induction of Labor in Multiparous Women
Primary: Time From Induction to Vaginal Delivery — 800; 693 minutes — p=0.11
Hereditary Orotic Aciduria
Primary: Patients With Stable Predetermined Principal Hematologic Parameters — 4 Participants